Our Services

PET/CT (18F-FDG) Body Imaging 

• useful in patients with certain malignancies (including but not limited to lung, breast, esophageal, gastrointestinal, colorectal, lymphoma, melanoma, multiple myeloma, thyroid, soft tissue sarcoma, head & neck, and cervical cancers), for initial staging, restaging, and radiation treatment planning  

PET/CT 18F-FDG Brain Imaging 

• useful in post-treatment patients with brain lesions, to determine radiation necrosis versus residual/recurrent malignancy 
• useful in patients with intractable epilepsy, to help locate the epileptogenic focus 
• useful in patients with dementia, to facilitate early diagnosis and to help determine type of dementia  

PET/CT 18F-Amyloid Brain Imaging 

• useful in patients with dementia, to detect or exclude Alzheimer’s disease 
• currently self-pay or associated with research only 

PET/CT 68GA-DOTATATE Body Imaging (NETSPOT)

• useful in patients with neuroendocrine and other somatostatin-receptor positive malignancies, for initial staging and restaging  

PET/CT 18F-Fluciclovine Body Imaging (Axumin) 

• useful in patients with suspected prostate cancer recurrence after primary treatment based on increasing serum PSA, to evaluate for local recurrence or distant metastases  

PET/CT 18F-NaF Bone Imaging  

• useful in patients with bone metastases, to detect and monitor treatment response 
• currently self-pay only 

Diagnostic CT Imaging 

Learn more in the links below.